Hybridomas are obtained by fusing normal B lymphocytes with a myeloma (tumor B cell line). Thus, a cloned hybridoma cell line has an unlimited capacity to grow in culture, producing immunoglobulin molecules with identical structure and antigen specificity, termed monoclonal antibodies (mAbs), which may have a wide variety of applications. We license 13 different hybridoma cell lines under the following conditions:

  • Worldwide license
  • Non-exclusive license
  • An up-front payment
  • Royalty on Sales
  • Without any right to sublicense
Ref: TEC0072

Fact Sheet TEC0072